Carl Trenz

Board Member
Carl currently serves as the Director of Therapy Development for Octapharma USA based in Hoboken, NJ. Octapharma is one of the largest human protein manufacturers in the world, developing and producing proteins from human plasma and human cell lines. His previous experience included time with both Eli Lilly and SmithKline Beecham.

He has been a member of the bleeding disorders community for over 17 years focusing on patient education and development. Carl earned his bachelor of science in business administration from West Virginia Wesleyan College.